Single Ascending Oral Doses of SY-009 in Healthy Subjects

NCT04119947 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: SY-009

Sponsor

Suzhou Yabao Pharmaceutical R&D Co., Ltd.